The drug delivery market is expected to grow at a CAGR of 7.83%, reaching a market size of US$1,246.822 billion in 2030 from US$1,071.016 billion in 2025. A drug delivery device is a specialized apparatus that is m...

The drug delivery market is expected to grow at a CAGR of 7.83%, reaching a market size of US$1,246.822 billion in 2030 from US$1,071.016 billion in 2025.
A drug delivery device is a specialized apparatus that is meant to be used for releasing drugs with precision and control. Over time, drugs increased the durability of human life, as well as improved human health; however, the way drugs are delivered has undergone significant changes in recent times. Through molecular biology methods, one can find drugs that interact with biological sites other than those assumed as targets hence causing non-severe side effects. Drug delivery systems regulate how much of the drug is released and where it goes. The market is rising due to the increasing cases of chronic diseases, the enlarged medical diagnostics industry, technological advancements, and new businesses springing up.
-
Growth Drivers of the Drug Delivery Market
The demand for drug delivery is also rising as the number of people with chronic diseases is on the rise. For instance, 8.89 million individuals succumbed to ischemic heart disease alone in 2019. Additionally, drug-delivery devices are increasingly accepted due to the escalating rate at which diabetes, cancer, and respiratory conditions are becoming common in the world. According to the National Institute of Health in India in 2022, there are roughly 21% of the older population of the country have chronic diseases, an increase in the instances of which will be instrumental in boosting biopharmaceuticals intake. The growing incidence of chronic illnesses is projected to provide support for the demand of pharmaceutical and drug delivery systems.
Further, the market expansion is anticipated to be driven by a rise in the use of cutting-edge technology to efficiently deliver medications to the target site. Additionally, by optimizing drug delivery at the target site, the use of these drug delivery devices lowers the likelihood of side effects. This aids in reducing the dosage and any related adverse effects.
Additionally, it is expected that the growing awareness on the advantages of drug delivery devices will drive market expansion in North America. In addition, approval of products from countries such as the USA are projected to spearhead development within the sector. The Vertiva which was produced by Stevenato group was launched in June 2023, this being a binding drug distribution system applied in multiple treatments and large-scale delivery implications.
-
Segmentation of the Drug Delivery Market
The drug delivery market, by type, is divided into five types- Inhalation Drug delivery, injectable drug delivery, nasal drug delivery, oral drug delivery, and transdermal drug delivery. Being deemed the most effective means for drugs reaching human bodies, injectable drug delivery is also declared the most effective means of administration. This is why they are said to be high on demand since prevalence rates for chronic illnesses globally are on the increase scale over the projected period. Furthermore, such illnesses include age-related conditions globally due to the population ageing and increases in healthcare expenditures.
The drug delivery market, by technique, is divided into four types- Needle-free injectors, drug delivery patches, autoinjectors, and others. Autoinjectors contain prefilled syringe and a spring-loaded mechanism for dispensing medicine. They are designed to help patients use their medicines at home without going to the hospital. These gadgets offer first aid solutions for instances such as anaphylaxis or severe allergy attacks and migraines as well as some long-term diseases such as multiple sclerosis (MS) or auto-immune disorders such as rheumatoid arthritis (RA) and systematic lupus erythematous industries. Instances of emergency conditions, including anaphylactic shock and migraine attacks, are becoming more common worldwide as a result of a number of causative factors, including food allergies, insect bites, and medication insensitivity. The need for biological therapies to treat these chronic diseases is great due to their increasing incidence.
The drug delivery market, by application, is divided into three types- Cancer treatment, infectious diseases treatment, and others. Cancer patients are being treated with a variety of cutting-edge drug delivery techniques. For the creation of cancer treatments, a broad variety of nanoscale compounds based on proteins, lipids, synthetic polymers, and organic and inorganic particles have been used.
The North America region is expected to witness significant growth in the drug delivery market during the forecasted period. The growing use of drug supply devices and the presence of significant players in the area are to blame for this. Furthermore, it is anticipated that growing regional awareness of the benefits of drug delivery devices will support market expansion in the area. Furthermore, rising product approval in nations like the United States is anticipated to support market expansion. The Stevanato Group introduced Vertiva in June 2023. It is a scalable drug distribution platform that can be used for a variety of therapies and high approach volumes.
-
Key Players in the Drug Delivery Market
The research includes several key players from the drug delivery market, such as Pfizer, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, Mersana Therapeutics, Becton, Dickinson and Company, Recipharm AB, Medtronic, Boston Scientific Corporation.
View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/drug-delivery-market
The analytics report categorizes the drug delivery market using the following::
- By Type
- Inhalation Drug Delivery
- Injectable Drug Delivery
- Nasal Drug Delivery
- Oral Drug Delivery
- Transdermal Drug Delivery
- By Technique
- Needle-free injectors
- Drug delivery patches
- Autoinjectors
- Others
- By Application
- Cancer treatment
- Infectious diseases treatment
- Others
- BY Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Others
- Asia Pacific
- China
- India
- South Korea
- Taiwan
- Thailand
- Indonesia
- Japan
- Others
- North America
- Drug Delivery System Market Report
- Novel Drug Delivery System Market Report
- Drug Delivery Polymer Market Size
Need specialized data cuts or competitive intelligence?
Our analyst team provides bespoke market sizing, supplier audits, and country-level feasibility reports tailored to your enterprise roadmap.
Speak With an Industry Analyst βAsk an Industry Analyst
Have questions regarding this briefing or market projections? Inquire with our sector lead.
Related Press Releases
View All β
ADC Manufacturing & CDMO Market is expected to reach USD 10.49 billion by 2031
Aug 7, 2026
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
Aug 5, 2026
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
Jul 30, 2026
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
Jul 24, 2026
Palliative Care in Oncology Market is expected to reach USD 244.1 billion by 2031
Jul 22, 2026More Press Releases
Oncology Drug Resistance Testing Market is projected to reach USD 3.41 billion in 2031 at a CAGR of 6.6 %
The oncology drug resistance testing market is expanding due to rising cancer prevalence, increasing drug resistance, and growing adoption of precision oncology. Advances in NGS-based testing, companion diagnostics, and targeted therapies, alongside FDA approvals and investments in personalized medicine, are accelerating demand for effective resistance monitoring across hospitals and clinical diagnostics worldwide.
TROP-2 Targeted Therapy Market is anticipated to surpass USD 3.29 billion in 2031 at a CAGR of 8.6 %
The TROP-2 Targeted Therapy market is expanding rapidly due to increasing precision oncology adoption, rising cancer prevalence, and growing use of antibody-drug conjugates. North America leads the market, while Asia Pacific shows the fastest growth. Continuous clinical trials, regulatory approvals, and strategic collaborations are accelerating innovation and commercial adoption worldwide.
Second Primary Cancer Prevention Market is expected to reach USD 24.7 billion by 2031
The Second primary cancer prevention refers to strategies aimed at reducing the risk of developing a new, unrelated cancer in individuals with a prior cancer diagnosis. Growing cancer survivorship, advances in treatment, and increasing awareness of long-term health outcomes have heightened the importance of prevention and surveillance programs. Key approaches include routine screening, genetic risk assessment, lifestyle modification, and long-term follow-up care. Government agencies and healthcare organisations increasingly emphasise survivorship care plans and evidence-based screening protocols to detect new malignancies at earlier stages. Continued investments in early detection technologies and personalised risk assessment are expected to support advancements in second primary cancer prevention.